£

Matthew Wilson Multiple Myeloma Fund

In 2021, after his own diagnosis, Matthew Wilson—now our Chair of Trustees—together with his family, joined forces with Blood Cancer UK to create the Matthew Wilson Multiple Myeloma Fund. The mission was clear: to find a cure for multiple myeloma.

Matthew Wilson Multiple Myeloma Fund logo

Why we established the Matthew Wilson Multiple Myeloma Fund

Every year, nearly 6,000 people in the UK are diagnosed with multiple myeloma. Although many respond well to initial treatments, the disease almost always returns. Our goal is to change this narrative.

Through the Matthew Wilson Multiple Myeloma Fund, we are committed to:

  • Advancing treatments: Investing in cutting-edge research to improve survival rates and quality of life.
  • Supporting new talent: Funding emerging leaders in multiple myeloma research.
  • Finding a cure: Driving innovation to bring us closer to a world where multiple myeloma is no longer life-threatening.

Our impact so far

Since its launch over two years ago, the fund has raised an incredible £6 million. This has allowed us to support some ground-breaking research projects focused on better diagnosis and treatment.

Find out more about a few of the projects we're funding through the Matthew Wilson Multiple Myeloma Fund below.

Understanding more about the causes of myeloma

Funded: A Clinical PhD studentship at University of Birmingham.

Read more about the causes of myeloma studentship.

Professor Chris Bunce stood in the lab smiling.

A new way of diagnosing and monitoring myeloma

Funded: Research project at University of Birmingham.

Find out more about the new way of diagnosing and monitoring myeloma project.

Dr Tracey Chan and Dr Jen Heaney stood in the lab together smiling.

Key molecules that help myeloma cells grow and thrive

Funded: Clinical PhD studentship at Imperial College London.

Find out more about the project understanding key molecules that help myeloma cells to grow in number and thrive.

A male scientist - Professor Karadimitris - poses for a photograph in his lab

Developing a more effective CAR-T therapy to treat myeloma

Funded: Research project at University College London.

Read more about the project Developing a more effective CAR-T therapy to treat myeloma.

Dr Paul Maciocia

“We’ve raised £6m in just two years together. I’m so proud of what this will mean for people affected by multiple myeloma, and am hugely thankful for all of you who’ve been with us on this journey so far.”

- Matthew Wilson, Chair of Trustees.

Celebrating progress

Impact reports

Our journey wouldn't be possible without the incredible support of the blood cancer community. See our impact reports below to find out more about how we're building breakthroughs together.

The future

We’re dedicated to turning research into real change for people with blood cancer. That’s why we’ve launched our Transformational Research Awards—funding big ideas that lead to new treatments, better diagnostics, and improved care.

These Transformational Research Awards will fund up to £1 million per project, and one will be dedicated to multiple myeloma research – funded directly though the Matthew Wilson Multiple Myeloma Fund. That’s all thanks to people like you.

With your continued support, we can change the future for people living with multiple myeloma.

Your support can help us make history. Donate today and be part of the movement to cure multiple myeloma.

  • If you would like to make a significant donation or discuss your personal contribution, please contact us at [email protected].
  • If your company is interested in partnering with the fund, reach out to our team at [email protected]
Matthew Wilson and his partner smile on a sunny day

Donate to the Matthew Wilson Multiple Myeloma Fund

Thank you for your generous support. Your donation brings us closer to the day we find a cure.

Donate to the fund